Search - tctmd.com

Displaying 121 - 140 of 140

Sort: Relevancy | Date

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Opinion Fellow Talk

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

Yashasvi Chugh, MD

August 16, 2018

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

News Conference News ACC 2018

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Yael L. Maxwell

March 15, 2018

News Conference News ACC 2018

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

Yael L. Maxwell

March 10, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

News Daily News

Public Reporting: Policy Changes in New York May Have Boosted PCI Rates of MI Complicated by Cardiogenic Shock

Todd Neale

July 28, 2016

News Daily News

CTA Both Clinically, Economically Comparable to Functional Testing for Suspected CAD

Leah Lawrence

May 25, 2016

News Daily News

Interhospital Transfer for Acute MI Associated With Disruptions in Aftercare, More Readmissions

L.A. McKeown

January 27, 2016

News Daily News

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

L.A. McKeown

January 12, 2016

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Industry News

Lilly Provides Update on Evacetrapib Phase 3 Trial

July 27, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Daily News

Study Looks at AMI Care in French Universal Coverage System

Jason Kahn

October 10, 2011

Advertisement

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

Discharge Against Medical Advice After PCI Rare but Deadly

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Public Reporting: Policy Changes in New York May Have Boosted PCI Rates of MI Complicated by Cardiogenic Shock

CTA Both Clinically, Economically Comparable to Functional Testing for Suspected CAD

Interhospital Transfer for Acute MI Associated With Disruptions in Aftercare, More Readmissions

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Lilly Provides Update on Evacetrapib Phase 3 Trial

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Study Looks at AMI Care in French Universal Coverage System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content